| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/23/1999 | CA2238671A1 Novel bmru |
| 01/23/1999 | CA2238667A1 Novel ferrichrome transport atp-binding protein |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/23/1999 | CA2238663A1 Novel hiss |
| 01/23/1999 | CA2238611A1 Novel lyss |
| 01/23/1999 | CA2238608A1 Novel cyss |
| 01/21/1999 | WO1999002991A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 01/21/1999 | WO1999002713A1 Pseudomonas exotoxin a-like chimeric immunogens |
| 01/21/1999 | WO1999002712A1 Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response |
| 01/21/1999 | WO1999002706A1 Glycosylation peptides |
| 01/21/1999 | WO1999002700A1 HISTIDINE KINASE TWO-COMPONENT IN $i(CANDIDA ALBICANS) |
| 01/21/1999 | WO1999002696A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | WO1999002695A2 Epitopes and active sites of paramyxoviridae proteins and uses thereof |
| 01/21/1999 | WO1999002681A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 01/21/1999 | WO1999002670A1 Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated |
| 01/21/1999 | WO1999002667A1 Mutations in the myostation gene cause double-muscling in mammals |
| 01/21/1999 | WO1999002661A2 Iron reductase |
| 01/21/1999 | WO1999002657A1 Rhabdoviruses with reengineered coats |
| 01/21/1999 | WO1999002565A2 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | WO1999002564A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002560A1 Hoqbq59 |
| 01/21/1999 | WO1999002554A2 Human herpesvirus-7 diagnostic and immunologic reagents and use thereof |
| 01/21/1999 | WO1999002550A1 Ctl epitopes from ebv |
| 01/21/1999 | WO1999002545A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | WO1999002187A2 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | WO1999002186A2 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/21/1999 | WO1999002184A1 Causative agent of sow abortion and mortality syndrome (sams), vaccine compositions, antibodies and method |
| 01/21/1999 | WO1999002183A2 A method of inducing a ctl response |
| 01/21/1999 | WO1999002182A2 Non-aqueous vaccines |
| 01/21/1999 | WO1999002180A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/21/1999 | WO1999002172A1 PHARMACEUTICAL FORMULATIONS COMPRISING VEGETAL MATERIAL SELECTED FROM $i(TRICHILIA) |
| 01/21/1999 | WO1999002132A2 Use of submicron oil-in-water emulsions with dna vaccines |
| 01/21/1999 | WO1998049312A3 Nucleic acids, proteins, and methods of use of granulocytic erhlichia |
| 01/21/1999 | WO1998046742A3 Dictyocaulus viviparus antigen for the diagnosis of lungworm disease and for vaccination |
| 01/21/1999 | WO1998046725A3 Attenuated, invasive vaccines against fish pathogens |
| 01/21/1999 | WO1998046640A3 Methods and compositions for inducing immunosuppression |
| 01/21/1999 | WO1998043657A3 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 01/21/1999 | WO1998031389A3 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/21/1999 | CA2298834A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | CA2296434A1 Mutations in the myostatin gene cause double-muscling in mammals |
| 01/21/1999 | CA2296092A1 Histidine kinase two-component in candida albicans |
| 01/21/1999 | CA2295964A1 A method of inducing a ctl response |
| 01/21/1999 | CA2295914A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 01/21/1999 | CA2295740A1 Use of submicron oil-in-water emulsions with dna vaccines |
| 01/21/1999 | CA2295735A1 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | CA2295688A1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | CA2295622A1 Pharmaceutical formulations comprising vegetal material selected from trichilia |
| 01/21/1999 | CA2295375A1 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | CA2295237A1 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 01/21/1999 | CA2295218A1 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | CA2294865A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/21/1999 | CA2294732A1 Ctl epitopes from ebv |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892064A2 Recombinant secA2 polypeptide from Staphylococcus aureus and uses thereof |
| 01/20/1999 | EP0892063A2 Histidine kinase |
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 01/20/1999 | EP0892061A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB |
| 01/20/1999 | EP0892060A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 01/20/1999 | EP0892059A2 Histidine kinase polypeptides |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892056A2 GidA1 polypeptides from Chlamydia trachomitis |
| 01/20/1999 | EP0892055A2 GidB polypeptides from Staphylococcus aureus |
| 01/20/1999 | EP0892054A1 Clostridium perfringens vaccine |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0892050A2 Human HFIZG53 |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891983A1 Novel tarF |
| 01/20/1999 | EP0891982A2 HIV peptides |
| 01/20/1999 | EP0891770A1 Killer T cell activator and use thereof |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891420A1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 01/20/1999 | EP0891377A1 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0445228B1 Immunotherapy involving cd28 stimulation |
| 01/20/1999 | CN1205738A OB protein derivatives having prolonged half-life |
| 01/20/1999 | CN1205613A Hybrid matrix implants and explants |
| 01/20/1999 | CN1205233A Analgesia medicine and its mfg. method |
| 01/20/1999 | CN1205204A Method and formulation for orally administering bioactive agents to and through the peyers patch |
| 01/20/1999 | CN1041750C Method for suspending, adsorbing and multiplicating virus of hepatitis A |
| 01/19/1999 | US5861500 Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof |
| 01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
| 01/19/1999 | US5861483 Inhibitor of stem cell proliferation and uses thereof |
| 01/19/1999 | US5861381 Pharmaceutical composition for the treatment of a malignant tumor |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
| 01/19/1999 | US5861282 Mutant constructs; vaccines; genetic engineering |
| 01/19/1999 | US5861281 Lacc |
| 01/19/1999 | US5861276 CDNAS encoding murine antibody against human plasma apolipoprotein B-100 |
| 01/19/1999 | US5861243 Amino acid sequences |
| 01/19/1999 | US5861241 Monoclonal antibodies for detecting Norwalk virus |
| 01/19/1999 | US5861164 Vaccination against diseases resulting from pathogenic responses by specific T cell populations |
| 01/19/1999 | US5861163 Immunnology and cells |
| 01/19/1999 | US5861162 Multivalent inocula for lessening incidence of liver abscesses in cattle |